全国慢性肾脏病队列中新发甲状腺功能减退症预测模型的开发与验证
本研究基于Optum Labs数据仓库中15642例4至5期慢性肾脏病且无既存甲状腺疾病的患者,开发并验证了新发甲状腺功能减退症(定义为促甲状腺激素TSH>5.0 mIU/L)的风险预测工具。中位随访3.4年期间共1650例(11%)发生新发甲状腺功能减退症。模型在开发集和验证集中的C统计量分别为0.77(95%CI 0.75-0.78)和0.76(95%CI 0.74-0.78),拟合优度检验在总体队列(P=0.47)和5期慢性肾脏病亚队列(P=0.33)中均显示充分拟合。
要点
- 中位随访3.4年期间,15642例4至5期慢性肾脏病患者中1650例(11%)发生新发甲状腺功能减退症。
- 与甲状腺功能减退症相关的特征包括年龄较大、白人种族、较高体重指数、低血清白蛋白、较高基线TSH、高血压、充血性心力衰竭、经血管造影或计算机断层扫描暴露于碘对比剂以及使用胺碘酮。
- 模型区分度良好,开发集C统计量0.77(95%CI 0.75-0.78),验证集0.76(95%CI 0.74-0.78)。
核心结论
- 在全国慢性肾脏病患者队列中,研究者开发了一种临床预测工具,用于识别新发甲状腺功能减退症风险较高的患者,以帮助在该人群中优先开展筛查、监测和治疗。
研究设计与样本
- 研究纳入15642例4至5期慢性肾脏病且无既存甲状腺疾病证据的患者,使用Optum Labs数据仓库(包含去标识化行政索赔数据,含医疗和药房索赔、商业和Medicare Advantage参保者登记记录以及电子健康记录数据)开发并验证新发甲状腺功能减退症(定义为促甲状腺激素TSH>5.0 mIU/L)的风险预测工具。
- 患者按三分之二作为开发集、三分之一作为验证集划分,预测模型采用Cox模型估计新发甲状腺功能减退症的概率。
主要发现
- 中位随访3.4年期间,共1650例(11%)发生新发甲状腺功能减退症。
- 与甲状腺功能减退症相关的特征包括年龄较大、白人种族、较高体重指数、低血清白蛋白、较高基线TSH、高血压、充血性心力衰竭、经血管造影或计算机断层扫描暴露于碘对比剂以及使用胺碘酮。
- 模型区分度良好,开发集C统计量为0.77(95%CI 0.75-0.78),验证集C统计量为0.76(95%CI 0.74-0.78)。
- 模型拟合优度检验显示总体队列拟合充分(P=0.47),5期慢性肾脏病亚队列拟合充分(P=0.33)。
临床怎么用
- 作者认为,该临床预测工具可识别新发甲状腺功能减退症风险较高的慢性肾脏病患者,以帮助在该人群中优先开展筛查、监测和治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Hypothyroidism is a common yet under-recognized condition in patients with chronic kidney disease (CKD), which may lead to end-organ complications if left untreated. OBJECTIVE: We developed a prediction tool to identify CKD patients at risk for incident hypothyroidism. METHODS: Among 15 642 patients with stages 4 to 5 CKD without evidence of pre-existing thyroid disease, we developed and validated a risk prediction tool for the development of incident hypothyroidism (defined as thyrotropin [TSH] > 5.0 mIU/L) using the Optum Labs Data Warehouse, which contains de-identified administrative claims, including medical and pharmacy claims and enrollment records for commercial and Medicare Advantage enrollees as well as electronic health record data. Patients were divided into a two-thirds development set and a one-third validation set. Prediction models were developed using Cox models to estimate probability of incident hypothyroidism. RESULTS: There were 1650 (11%) cases of incident hypothyroidism during a median follow-up of 3.4 years. Characteristics associated with hypothyroidism included older age, White race, higher body mass index, low serum albumin, higher baseline TSH, hypertension, congestive heart failure, exposure to iodinated contrast via angiogram or computed tomography scan, and amiodarone use. Model discrimination was good with similar C-statistics in the development and validation datasets: 0.77 (95% CI 0.75-0.78) and 0.76 (95% CI 0.74-0.78), respectively. Model goodness-of-fit tests showed adequate fit in the overall cohort (P = .47) as well as in a subcohort of patients with stage 5 CKD (P = .33). CONCLUSION: In a national cohort of CKD patients, we developed a clinical prediction tool identifying those at risk for incident hypothyroidism to inform prioritized screening, monitoring, and treatment in this population.
引用
- Rhee CM, You AS, Narasaki Y, et al. Development and Validation of a Prediction Model for Incident Hypothyroidism in a National Chronic Kidney Disease Cohort. J Clin Endocrinol Metab. 2023. PMID: 37186674. doi:10.1210/clinem/dgad261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。